Comparison

Foundayo vs. Compounded Semaglutide: Cost, Efficacy, and the Compounding Patient's Calculus

Updated June 2026

In April 2026, the FDA approved Foundayo (orforglipron) — the first oral GLP-1 pill with no food, water, or timing restrictions. For patients currently on compounded semaglutide, this creates a new question: is it time to switch to an FDA-approved oral option?

Here's a direct comparison across the factors that actually matter.

Head-to-Head Comparison

FactorFoundayo (Orforglipron)Compounded Injectable Semaglutide
FDA approvedYesNo
FormatDaily pillWeekly injection
Weight loss (72wk)7.5–11.2%~15% (same molecule as Wegovy)
Food/water rulesNoneN/A (injection)
StorageRoom temp (protect from light)Refrigerate
Regulatory riskNone — FDA-approvedOngoing — 503B exclusion pending, 503A under scrutiny
Monthly costBrand pricing (TBD)$99–$299/mo
Medicare Bridge eligibleYes ($50/mo)No
Insurance coverageExpandingNone

When Compounded Still Wins

Cost without insurance: At $99–$149/month through telehealth providers, compounded semaglutide remains significantly cheaper than any brand-name GLP-1 without insurance coverage. If you're paying cash and Foundayo's brand pricing lands at $500+/month (likely), the math still favors compounded.

Weight loss efficacy: Compounded semaglutide delivers the same molecule as Wegovy, which achieves ~15% weight loss at 72 weeks. Foundayo's maximum was 11.2%. For patients who need maximum weight reduction, injectable semaglutide still delivers more.

Dose flexibility: Compounding pharmacies can create custom titration schedules and doses not available in commercial products. Some patients benefit from non-standard dose steps.

When Foundayo Wins

Regulatory certainty: No risk of supply disruption from regulatory action. The compounded GLP-1 landscape is shifting fast — Foundayo will be available regardless.

No injections: For needle-averse patients, a daily pill eliminates the biggest barrier to starting treatment.

Medicare coverage: Starting July 1, 2026, Medicare covers Foundayo at $50/month through the GLP-1 Bridge. Compounded medications are excluded.

Travel convenience: No refrigeration, no sharps, no explaining vials at airport security. Just a pill bottle.

The Decision Framework

⚡ Switch to Foundayo if:
You have insurance that covers it, you qualify for Medicare's GLP-1 Bridge, you're uncomfortable with compounding's regulatory uncertainty, or you strongly prefer a daily pill over weekly injections.
⚡ Stay on Compounded if:
Cost is your primary driver and you're paying cash, you need maximum weight loss efficacy (>11%), you're comfortable with your pharmacy's compliance and quality, or you benefit from custom dosing.

Compounded Providers to Compare

GobyMedsDIRECT AFFILIATE
LegitScript · 503A+503B · Free consult & shipping · Also offers NAD+ & Sermorelin
$99/mo sema bundle
Compounded Sema — $99/mo →
Paid link · Direct affiliate
Compounded medications are not FDA-approved. They are prepared by licensed pharmacies based on a prescription and are not subject to the same regulatory review as commercially manufactured drugs.
Embody
Injectable semaglutide · Free consult · Ships nationwide
$149 first month
Compounded Sema — $149 First Month →
Paid link
Compounded medications are not FDA-approved. They are prepared by licensed pharmacies based on a prescription and are not subject to the same regulatory review as commercially manufactured drugs.

Brand-Name Access

Sesame Care
Brand-name FDA-approved medications only
See site
Foundayo / Wegovy Access →
Paid link

Compare Compounding Pharmacy Providers

See pricing, pharmacy type, and what's included — side by side.

Compare Providers →